Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17944
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChiew, Angela L-
dc.contributor.authorWright, Daniel F B-
dc.contributor.authorDobos, Nicola M-
dc.contributor.authorMcArdle, Kylie-
dc.contributor.authorMostafa, Ahmed A-
dc.contributor.authorNewth, Annemarie-
dc.contributor.authorRoberts, Michael S-
dc.contributor.authorIsbister, Geoffrey K-
dc.date2018-03-13-
dc.date.accessioned2018-06-21T05:42:58Z-
dc.date.available2018-06-21T05:42:58Z-
dc.date.issued2018-12-
dc.identifier.citationBritish journal of clinical pharmacology 2018; 84(12): 2923-2927-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17944-
dc.description.abstractMassive metformin overdose can cause metabolic acidosis with hyperlactatemia. A 55-year-old woman presented 5 h after multidrug overdose, including 132 g extended-release metformin. Continuous venovenous haemodiafiltration (CVVHDF) and noradrenaline were commenced due to metabolic acidosis (pH 7.0, lactate 17 mmol l-1 ) and shock. Despite 3 h of CVVHDF, her acidosis worsened (pH 6.83, lactate 24 mmol l-1 ). Intermittent haemodialysis (IHD) improved acidosis (pH 7.13, lactate 26 mmol l-1 ) but again worsened (pH 6.91, lactate 30 mmol l-1 ) with CVVHDF recommencement. IHD (12 h), CVVHDF (26 h) and vasopressor support for 7 days resulted in survival. Measured metformin concentrations were extremely high with a peak of 292 μg ml-1 at 8 h postingestion. IHD, but not CVVHDF in this case, was associated with improvement in metabolic acidosis and hyperlactataemia. Pharmacokinetic analysis of metformin concentrations found a reduced apparent oral clearance of 8.2 l h-1 and a half-life of approximately 30 h. During IHD, the apparent oral clearance increased to 22.2 l h-1 with an approximate half-life of 10 h. The impact of prolonged oral absorption from a pharmacobezoar and redistribution of metformin from peripheral sites (including erythrocytes) on the pharmacokinetic profile cannot be determined from the data available.-
dc.language.isoeng-
dc.subjectextracorporeal elimination-
dc.subjectmetabolic acidosis-
dc.subjectmetformin-
dc.subjectoverdose-
dc.title'Massive' metformin overdose.-
dc.typeJournal Article-
dc.identifier.journaltitleBritish journal of clinical pharmacology-
dc.identifier.affiliationNew South Wales Poisons Information Centre, Children's Hospital at Westmead, Westmead, New South Wales, Australia-
dc.identifier.affiliationSchool of Pharmacy, University of Otago, Dunedin, New Zealand-
dc.identifier.affiliationIntensive Care Unit, Western Health, Melbourne, Victoria, Australia-
dc.identifier.affiliationSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia-
dc.identifier.affiliationVictorian Poisons Information Centre, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationPharmaceutical Chemistry Department, Helwan University, Helwan, Egypt-
dc.identifier.affiliationTranslational Research Institute, Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia-
dc.identifier.affiliationDepartment of Emergency Medicine, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationClinical Toxicology Research Group, University of Newcastle, Callaghan, New South Wales, Australia-
dc.identifier.doi10.1111/bcp.13582-
dc.identifier.orcid0000-0002-0079-5056-
dc.identifier.orcid0000-0001-9313-9252-
dc.identifier.orcid0000-0003-1519-7419-
dc.identifier.pubmedid29534338-
dc.type.austinJournal Article-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

12
checked on Nov 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.